← Back to Search

Behavioral Intervention

Yoga Breathing for Breast Cancer

N/A
Waitlist Available
Led By Sundar Balasubramanian, PhD
Research Sponsored by Sundar Balasubramanian
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This trial is testing a new app that uses yogic breathing to help reduce symptoms for cancer survivors and support total-health.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of study application measured by participant ability to perform all study procedures.
Participants' symptom management as measured by a focus group.
Participants' symptom management as measured by emotional disposition.
+3 more
Secondary outcome measures
Behavioral Survey Measures through Depression Scale.
Behavioral Survey Measures through MD Anderson Symptom Inventory.
Behavioral Survey Measures through Perceived Stress.
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Yoga Breathing (YB)Experimental Treatment1 Intervention
A first production version of a mobile application that guides users through proscribed yoga breathing exercises.
Group II: Attention ControlExperimental Treatment1 Intervention
A first production version of a mobile application that guides users through an attention control activity, presented as methods for mindfulness.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Attention Control
2014
Completed Phase 2
~6520

Find a Location

Who is running the clinical trial?

Sundar BalasubramanianLead Sponsor
PranaScience Institute LLCIndustry Sponsor
National Cancer Institute (NCI)NIH
13,606 Previous Clinical Trials
40,913,444 Total Patients Enrolled
938 Trials studying Breast Cancer
1,543,293 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals still partake in this investigation?

"According to clinicaltrials.gov, this active medical trial first went live on November 17th 2021 and was recently updated on July 28th 2022."

Answered by AI

How many participants are eligible for enrollment in this clinical study?

"Affirmative. According to the clinicaltrials.gov website, this experiment was first shared on November 17th 2021 and is actively seeking participants. 40 volunteers are needed at a single medical centre for successful completion of this trial."

Answered by AI

What are the aims of this investigation?

"The primary indicator of success that will be measured every 12 weeks is the System Usability Scale, which assesses symptom management. Additional data points include scores from Depression Scale and MD Anderson Symptom Inventory questionnaires, as well as exploratory salivary and fingernail biomarkers collected pre-and post-study session at Weeks 1 and 12 through proteomic multiplexing and ELISA testing."

Answered by AI
~12 spots leftby Mar 2025